The Journal
Education first, always.
Semaglutide for Women: The Questions the Trials Skipped
Semaglutide has one of the larger completed clinical trial programs among compounds discussed in this catalog, and like tirzepatide, that program included…
Read more →
Tirzepatide Benefits for Women Sit in Unstratified Trial Data
Tirzepatide’s trial population included women in substantial numbers, which puts it ahead of most compounds in this catalog on that count alone.…
Read more →
Peptides vs Steroids Are Not the Same Thing
Peptides and anabolic steroids get compared constantly in fitness and performance discussion, usually with the implication that peptides are the gentler, more…
Read more →
SARMs vs Peptides Are Not the Same Category
Peptides and SARMs get grouped together constantly in fitness and research forums, treated as adjacent tools from the same shelf. They are…
Read more →
Nobody Actually Tested Peptide Cycling
Cycling is vocabulary borrowed wholesale from anabolic steroid culture, carried into peptide discussion with an implied body of dosing science that does…
Read more →
Peptides for Weight Loss and Muscle Gain: Both at Once?
Losing fat while gaining muscle is the outcome almost everyone actually wants and the one the research is least equipped to speak…
Read more →
What 99% Actually Means in Peptide Purity Testing
Purity testing is the entire basis on which a research peptide can be trusted, and the certificate reporting it is usually read…
Read more →
Peptides for Acne Only Touch One Part of the Problem
Acne is a diagnosable skin condition with an inflammatory component, which places it in a different category from the cosmetic firmness and…
Read more →
Retatrutide vs Semaglutide (Ozempic): What the Trial Data Compares
Retatrutide and semaglutide sit at opposite ends of the same compound family’s development timeline, and comparing them means comparing a fully approved,…
Read more →